Alector (ALEC) Non-Current Deffered Revenue (2018 - 2026)

Alector (ALEC) reported Non-Current Deffered Revenue of $162.9 million for Q1 2026, down 4.37% year-over-year from $170.3 million in Q1 2025, and down 1.02% quarter-over-quarter from $164.5 million in Q4 2025.

Alector (ALEC) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Non-Current Deffered Revenue data on file, last reported at $162.9 million in Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $162.9 million, down 4.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $162.9 million (down 4.37% YoY), and the FY2025 annual result was $164.5 million, down 4.43% from the prior year.
  • Non-Current Deffered Revenue slipped to $162.9 million in Q1 2026 per ALEC's latest filing, from $164.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $505.1 million in Q1 2022 and troughed at $162.9 million in Q1 2026.
  • A 5-year average of $262.9 million and a median of $204.6 million in 2024 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue jumped 378.83% in 2022, then slumped 52.54% in 2024.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $443.4 million in 2022, then sank by 52.44% to $210.8 million in 2023, then fell by 18.34% to $172.2 million in 2024, then fell by 4.43% to $164.5 million in 2025, then slipped by 1.02% to $162.9 million in 2026.
  • Business Quant data shows ALEC's Non-Current Deffered Revenue at $162.9 million in Q1 2026, $164.5 million in Q4 2025, and $167.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Alector 193.53 Mn -12.98 Mn - 162.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 162.87 Mn
Dec 31, 2025 164.54 Mn
Sep 30, 2025 167.27 Mn
Jun 30, 2025 168.87 Mn
Mar 31, 2025 170.31 Mn
Dec 31, 2024 172.17 Mn
Sep 30, 2024 192.78 Mn
Jun 30, 2024 199.58 Mn
Mar 31, 2024 204.58 Mn
Dec 31, 2023 210.85 Mn
Sep 30, 2023 229.85 Mn
Jun 30, 2023 245.34 Mn
Mar 31, 2023 431.08 Mn
Dec 31, 2022 443.37 Mn
Sep 30, 2022 386.36 Mn
Jun 30, 2022 413.90 Mn
Mar 31, 2022 505.13 Mn
Dec 31, 2021 334.42 Mn
Sep 30, 2021 344.53 Mn
Jun 30, 2021 96.21 Mn